vs
Side-by-side financial comparison of Agilent Technologies (A) and MARRIOTT VACATIONS WORLDWIDE Corp (VAC). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.2B, roughly 1.5× MARRIOTT VACATIONS WORLDWIDE Corp). Agilent Technologies runs the higher net margin — 17.0% vs -35.0%, a 52.0% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs -0.7%). Agilent Technologies produced more free cash flow last quarter ($175.0M vs $-6.0M). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs 5.2%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Marriott Vacations Worldwide Corporation is a pure-play public timeshare company. Formerly a division of Marriott International, Marriott Vacations Worldwide was established as a separate, publicly traded entity focusing primarily on vacation ownership in November 2011. Marriott Vacations Worldwide runs more than 120 resorts with over 700,000 Owners and members in a diverse portfolio of brands under The Marriott Vacation Clubs name. Its brands include Marriott Vacation Club, The Marriott Vaca...
A vs VAC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.2B |
| Net Profit | $305.0M | $-431.0M |
| Gross Margin | 52.6% | — |
| Operating Margin | 19.6% | — |
| Net Margin | 17.0% | -35.0% |
| Revenue YoY | 7.0% | -0.7% |
| Net Profit YoY | -4.1% | -962.0% |
| EPS (diluted) | $1.07 | $-12.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.1B |
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-431.0M | ||
| Q3 25 | $336.0M | $-2.0M | ||
| Q2 25 | $215.0M | $69.0M | ||
| Q1 25 | $318.0M | $56.0M | ||
| Q4 24 | $351.0M | $50.0M | ||
| Q3 24 | $282.0M | $84.0M | ||
| Q2 24 | $308.0M | $37.0M |
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 22.4% | — | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | — | ||
| Q2 24 | 23.1% | — |
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -35.0% | ||
| Q3 25 | 19.3% | -0.2% | ||
| Q2 25 | 12.9% | 6.0% | ||
| Q1 25 | 18.9% | 5.0% | ||
| Q4 24 | 20.6% | 4.0% | ||
| Q3 24 | 17.9% | 6.9% | ||
| Q2 24 | 19.6% | 3.5% |
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-12.00 | ||
| Q3 25 | $1.18 | $-0.07 | ||
| Q2 25 | $0.75 | $1.77 | ||
| Q1 25 | $1.11 | $1.46 | ||
| Q4 24 | $1.23 | $1.29 | ||
| Q3 24 | $0.97 | $2.12 | ||
| Q2 24 | $1.05 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $406.0M |
| Total DebtLower is stronger | $3.0B | — |
| Stockholders' EquityBook value | $6.9B | $2.0B |
| Total Assets | $12.8B | $9.8B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $406.0M | ||
| Q3 25 | $1.5B | $474.0M | ||
| Q2 25 | $1.5B | $205.0M | ||
| Q1 25 | $1.5B | $196.0M | ||
| Q4 24 | $1.3B | $197.0M | ||
| Q3 24 | $1.8B | $197.0M | ||
| Q2 24 | $1.7B | $206.0M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $2.0B | ||
| Q3 25 | $6.4B | $2.5B | ||
| Q2 25 | $6.1B | $2.5B | ||
| Q1 25 | $6.0B | $2.4B | ||
| Q4 24 | $5.9B | $2.4B | ||
| Q3 24 | $5.9B | $2.4B | ||
| Q2 24 | $6.2B | $2.4B |
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $9.8B | ||
| Q3 25 | $12.2B | $10.1B | ||
| Q2 25 | $12.2B | $9.9B | ||
| Q1 25 | $11.9B | $9.9B | ||
| Q4 24 | $11.8B | $9.8B | ||
| Q3 24 | $11.0B | $9.7B | ||
| Q2 24 | $10.9B | $9.6B |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | $6.0M |
| Free Cash FlowOCF − Capex | $175.0M | $-6.0M |
| FCF MarginFCF / Revenue | 9.7% | -0.5% |
| Capex IntensityCapex / Revenue | 5.2% | 1.0% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | $-29.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $6.0M | ||
| Q3 25 | $362.0M | $62.0M | ||
| Q2 25 | $221.0M | $-48.0M | ||
| Q1 25 | $431.0M | $8.0M | ||
| Q4 24 | $481.0M | $100.0M | ||
| Q3 24 | $452.0M | $72.0M | ||
| Q2 24 | $333.0M | $30.0M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $-6.0M | ||
| Q3 25 | $259.0M | $51.0M | ||
| Q2 25 | $107.0M | $-68.0M | ||
| Q1 25 | $334.0M | $-6.0M | ||
| Q4 24 | $388.0M | $86.0M | ||
| Q3 24 | $360.0M | $58.0M | ||
| Q2 24 | $230.0M | $17.0M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | -0.5% | ||
| Q3 25 | 14.9% | 4.3% | ||
| Q2 25 | 6.4% | -5.9% | ||
| Q1 25 | 19.9% | -0.5% | ||
| Q4 24 | 22.8% | 6.9% | ||
| Q3 24 | 22.8% | 4.8% | ||
| Q2 24 | 14.6% | 1.6% |
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.0% | ||
| Q3 25 | 5.9% | 0.9% | ||
| Q2 25 | 6.8% | 1.7% | ||
| Q1 25 | 5.8% | 1.3% | ||
| Q4 24 | 5.5% | 1.1% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 1.2% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | -0.70× | ||
| Q1 25 | 1.36× | 0.14× | ||
| Q4 24 | 1.37× | 2.00× | ||
| Q3 24 | 1.60× | 0.86× | ||
| Q2 24 | 1.08× | 0.81× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
VAC
| Cost Reimbursement | $467.0M | 38% |
| Time Share | $381.0M | 31% |
| Management And Exchange | $212.0M | 17% |
| Ancillary Revenues | $64.0M | 5% |
| Management Service | $55.0M | 4% |
| Service Other | $36.0M | 3% |
